Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06725186 · ClinicalTrials.gov registry record · NA
Regulating Emotions Like An eXpert Among Adolescents With ADHD
A NA study of RELAX Telehealth Intervention and Psychoeducational Waitlist Control, sponsored by Virginia Polytechnic Institute and State University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06725186: Recruiting NA study of RELAX Telehealth Intervention and Psychoeducational Waitlist Control, sponsored by Virginia Polytechnic Institute and State University.
NCT06725186 is a NA study of RELAX Telehealth Intervention and Psychoeducational Waitlist Control that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06725186, a NA study of RELAX Telehealth Intervention and Psychoeducational Waitlist Control, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study consists of a randomized controlled trial assessing the acceptability, feasibility, and efficacy of the RELAX (Regulating Emotions Like An eXpert) Intervention. Following randomization, 30 families will receive the RELAX intervention and 30 families will receive psychoeducational materials as part of a control condition. Additionally, 10 families from the RELAX condition will participate in a pilot study and focus groups to give feedback on developed smartphone apps to support skill use during and following completion of RELAX.
Primary Outcome
The DERS-SF will be used to assess emotion regulation problems (e.g., poor emotion awareness, poor emotion clarity, non-acceptance of emotions, poor access to emotion regulation strategies). The DERS will be completed at all timepoints by both parents and adolescents, with parents completing ratings for themselves and for their adolescents. The 18 DERS items are rated on a 5-point scale ranging from 1 - Almost Never (0-10%) to 5 - Almost Always (91-100%) and the total score represents a sum acro
Conditions Studied
Interventions
- BEHAVIORAL RELAX
- BEHAVIORAL Psychoeducational Materials
Study Locations (1)
Virginia
- Child Study Center - Blacksburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06725186 shows while recruiting
NCT06725186 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with RELAX Telehealth Intervention appearing as the primary indexed condition, and to 2 interventions - of which RELAX is the first listed.
NCT06725186 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06725186 about?
NCT06725186 is a clinical study titled "Regulating Emotions Like An eXpert Among Adolescents With ADHD". This study consists of a randomized controlled trial assessing the acceptability, feasibility, and efficacy of the RELAX (Regulating Emotions Like An eXpert) Intervention. Following randomization, 30 families will receive the RELAX intervention and 30 families will receive psychoeducational material...
What is the current status of trial NCT06725186?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-15. Estimated completion is 2028-12.
What conditions does trial NCT06725186 study?
This clinical trial studies the following conditions: RELAX Telehealth Intervention, Psychoeducational Waitlist Control, EMI Smartphone App Pilot.
What interventions are being tested in trial NCT06725186?
The interventions under investigation include: RELAX (BEHAVIORAL), Psychoeducational Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT06725186?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06725186 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06725186's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI